3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Epilepsy
1
Child Development Disorders, Pervasive
1
Autistic Disorder
1
Interventions
Everolimus
5
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sirolimus
1
Sevelamer
1
Sertraline
1
Selective Serotonin Reuptake Inhibitors
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Magnetoencephalography
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Autistic Disorder
×
Activator Appliances
×
Clear all
NCT03422367
2020-11-06
JETS
University of California, Los Angeles
Phase NA
Unknown
64 enrolled